Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
Rapid Micro Biosystems announced its financial results for Q2 2026, showing total revenue of $8.1 million, an 11% growth year-over-year, driven by increased placement and validation of Growth Direct systems. The company achieved record gross margins of 15%, improving significantly from the prior year, and reaffirmed its full-year 2026 revenue guida…